Track topics on Twitter Track topics that are important to you
Myriad Genetics and Cepheid are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitabiliy, institutional ownership and earnings. 95.8% of Cepheid shares are owned by institutional investors.
Original Article: Reviewing Myriad GeneticsNEXT ARTICLE